Quadrant licenses epigenetic diagnostics from SUNY, Penn State

Quadrant Biosciences Inc. (Syracuse, N.Y.) licensed three epigenetic biomarkers from the State University of New York Upstate Medical University and Pennsylvania State University for autism spectrum disorder (ASD), Parkinson's disease and traumatic brain injury (TBI).

The company plans to commercialize an ASD diagnostic this year...